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2-Cyanoacetohydrazide;
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1,2-DihydropyridineAbstract Synthesis of novel derivatives of 5,6-dimethoxy-1-indanone was carried out via its
Schiff’s base using 2-cyanoacetohydrazide followed by cyclization with 2-arylidenemalononitrile
in the presence of a catalytical amount of piperidine to get 6-amino-1-(5,6-dimethoxy-2,3-
dihydro-1H-inden-1-ylideneamino)-2-oxo-4-aryl-1,2-dihydropyridine-3,5-dicarbonitrile derivatives.
The structures of the synthesized compounds were conﬁrmed on the basis of their spectral and ele-
mental analysis. The synthesized compounds were also screened for antimicrobial activity and
found to have promising antibacterial activity.
ª 2014 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
The pyridine nucleus is of considerable interest as this ring is
the key constituent in a range of bioactive compounds, both
naturally occurring and synthetic, and often of considerable
complexity (Boger and Nakahara, 1991). The pyridine dicar-
bonitrile substructure was therefore chosen as a basic struc-
tural scaffold for the design of a reaction-based library
(Reddy et al., 2006). Many publications report the biologicalproperties of pyridinedicarbonitriles as being antihypertensive
(Ward, 1976), antihistaminic (Quintela et al., 1997), antican-
cer, (Cocco et al., 2007) anti-inﬂammatory, analgesic (Manna
et al., 1992), antibacterial (Behbehani et al., 2012), anti-HIV
agents (El-Hawash et al., 2006) and anti-Alzheimer (Samadi
et al., 2010). Many derivatives of pyridine-3,5-dicarbonitrile
are reported as potential therapeutic agents, In hope to dis-
cover novel therapeutic agents, a series of 6-amino-1-(5,
6-dimethoxy-2,3-dihydro-1H-inden-1-ylideneamino)-2-oxo-
4-aryl-1,2-dihydropyridine-3,5-dicarbonitrile compound are
prepared which have not been reported before and compounds
are tested for their antibacterial and antifungal activities.icrobial
2 V.M. Patel et al.2. Experimental
2.1. Materials and methods
Melting points were determined in open capillary tubes and are
uncorrected. NMR was recorded either in CDCl3 or DMSO-d6
on a Bruker Avance 400 Hz and signal is given in ppm (d) rel-
ative to TMS. Elementary analyses were taken on Euro EA
3000 elementary analysis instrument. LCMS were measured
on Agilent 1100 Series MS spectrometer. TOF MS were mea-
sured on a Waters ZQ 2000 spectrometer. All the solvent and
materials are of reagent grade and puriﬁed before use. Purity
of all reagent and product was checked by TLC (hexane:ethyl-
acetate; 70:30).O
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2-cyanoacetohydrazide
R= Ph, 4-OMePh, 4-ClPh, 3-BrPh, 3-OMePh, 3-OMe-4-OHPh, 
3-FPh, 3-ClPh, 3-OMePh, 3-NO2Ph, 3-OEtPh2.2. Procedure for the preparation of 2-cyano-N0-(5,6-
dimethoxy-2,3-dihydro-1H-inden-1-ylidene)acetohydrazide (2)
To the mixture of (0.0026 moles) of 5,6-dimethoxy-1-indanone
and 15.0 ml Ethanol, (0.0026 moles) of 2-cyanoacetohydrazide
is heated to reﬂux temperature, to the suspension and 1–2
drops of conc. hydrochloric acid is added, reaction mixture
was reﬂuxed till disappearance of raw material. Completion
of reaction was monitored by TLC (hexane:ethylacetate:meth-
anol; 5:5:2). Solid was collected by ﬁltration and recrystallized
with ethanol.
2.3. General procedure for the preparation of 2-
arylidenemalononitrile 3(a–k)
The mixture of aromatic aldehydes (0.03 moles), malononitri-
le (0.03 moles) and (piperidinecatalytic amount) in 35 ml eth-
anol was stirred at room temperature for 1.5 h. The
precipitate is allowed to stand overnight, collected by suction
ﬁltration washed with cold ethanol, and ﬁnally dried at the
room temperature. Used for successive step without puriﬁca-
tion. Purity of all the compounds has been checked by TLC
and compared with reported mp (Sakurai et al., 1972).Please cite this article in press as: Patel, V.M. et al., Novel derivatives of 5,6-dime
agents. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.20142.4. General procedure for the preparation of 6-amino-1-(5,6-
dimethoxy-2,3-dihydro-1H-inden-1-ylideneamino)-2-oxo-4-aryl-
1,2-dihydropyridine-3,5-dicarbonitrile derivatives 4(a–k)
To a solution of 2 (2 mmoles) in ethanol (10 ml) was added the
appropriate 2-arylidenemalonitrile (3a–3k) (2 mmoles) and four
drops of piperidine. Themixture was reﬂuxed 3–5 h. Themixture
was cooled and the separated crystalline product was ﬁltered,
washed with ethanol, dried and recrystallized from ethanol.
2.5. Characterization of synthesized Compounds
2.5.1. 2-cyano-N0-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylidene)acetohydrazide (2)Off white solid; Yield: 620 mg (87%), mp 230–231 C, 1H
NMR (400 MHz,CDCl3) d ppm= 9.22 (s, 1H, NH), 7.15 (s,
1H, ArH), 6.56 (s, 1H, ArH), 3.91 (d, J = 1.6 Hz,
6H,2OCH3), 3.80 (s, 2 H,CH2CN), 3.07 (t, 2 H,CH2), 2.88
(t, 2 H,CH2),
13C NMR (40 MHz, CDCl3) d ppm = 160.3,
156.0, 151.3, 147.9, 139.4, 125.7, 116.2, 110.9, 105.9, 56.5,
56.4, 28.8, 27.8, 24.2., IR (cm1): 2214, 2935, 1680, 1329.,
m/z: 274.11, Anal. Cald for C14H15N3O3: C, 61.53; H, 5.53;
N, 15.38; O, 17.56; Found: C, 61.53; H, 5.53; N, 15.38.
2.5.2. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(4-methoxyphenyl)-2-oxo-1,2-
dihydropyridine-3,5-dicarbonitrile (4a)
Orange powder, Yield: 330 mg (40%), mp 236–238 C, 1H
NMR (400 MHz, DMSO-d6) d ppm= 10.35 (s, 3 H,
NH2),7.77–7.75 (d, 1H, ArH), 7.05 (s, 1H, ArH), 7.02–7.01
(d, 1H, ArH), 6.84 (s, 1H, ArH), 3.92 (s, 6 H, 2OCH3), 3.85
(s, 3 H, OCH3), 3.10–3.07 (t, 2 H, indane CH2), 2.65–2.62 (t,
2 H, indane CH2) ppm;
13C NMR (40 MHz, DMSO-d6) d
ppm= 166.0, 161.9, 160.4, 155.0, 148.5, 142.4, 128.9, 128.8,
127.2, 117.1, 113.9, 110.1, 106.8, 82.1, 71.1, 56.5, 56.4, 55.2,
29.5, 28.1 ppm; LCMS: m/z 454.5 (M+), Anal. Cald for
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4a2.5.3. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-2-oxo-4-phenyl-1,2-dihydropyridine-3,5-
dicarbonitrile (4b)
Grey powder, Yield: 280 mg (36%), mp 218–221 C, 1H NMR
(400 MHz, DMSO-d6) d ppm= 10.02 (s, 2 H, NH2), 8.04–8.01
(d, 1H, ArH), 7.57–7.52 (t, 1H, ArH), 7.29–7.25 (t, 1H, ArH),
7.04 (s, 1H, ArH), 6.84 (s, 1H, ArH), 3.92 (s, 6 H, 2OCH3),
3.10–3.07 (t, 2 H, indane CH2), 2.66–2.62 (t, 2 H, indane
CH2) ppm;
13C NMR (40 MHz, DMSO-d6) d ppm= 166.4,
160.4, 155.0, 151.0, 150.3, 148.5, 133.9, 131.0, 129.3, 128.9,
128.7, 117.0, 113.6, 110.1, 106.8, 91.9, 71.6, 56.5, 56.4, 29.5,
28.1 ppm; LCMS: m/z 424.0 (M+), Anal. Cald for
C24H19N5O3: C,67.76;H,4.50;N,16.46;O,11.28; Found:
C,67.80;H,4.60;N,16.53.
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4b2.5.4. 6-Amino-4-(4-chlorophenyl)-1-(5,6-dimethoxy-2,3-
dihydro-1H-inden-1-ylideneamino)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4c)
Light Yellow powder, Yield: 350 mg (42%), mp 225–229 C,
1H NMR (400 MHz, DMSO-d6) d ppm= 10.08 (s, 2 H,
NH2), 8.01–7.99 (d, 1H, ArH), 7.38–7.35 (d, 1H, ArH), 7.05
(s, 1H, ArH), 6.83 (s, 1H, ArH), 3.92 (s, 6 H, 2OCH3), 3.10–
3.07 (t, 2 H, indane CH2), 2.66–2.64 (t, 2 H, indane CH2)
ppm; 13C NMR (40 MHz, DMSO-d6) d ppm = 165.6, 160.4,
155.0, 151.1, 150.3, 142.4, 134.7, 132.1, 130.6, 128.9, 127.9,
117.1, 110.1, 106.8, 92.3, 72.3, 56.5, 56.4, 29.5, 28.1 ppm;
LCMS: m/z 460.9 (M+), Anal. Cald for C24H18ClN5O3:-
C,62.68;H,3.95;Cl,7.71;N,15.23;O,10.44; Found:
C,62.90;H,3.89;N,15.28.
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4cPlease cite this article in press as: Patel, V.M. et al., Novel derivatives of 5,6-dime
agents. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.20142.5.5. 6-Amino-4-(3-bromophenyl)-1-(5,6-dimethoxy-2,3-
dihydro-1H-inden-1-ylideneamino)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4d)
Yellow powder, Yield: 520 mg (65%), mp 255–259 C, 1H
NMR (400 MHz, DMSO-d6) d ppm = 9.98 (s, 2 H, NH2),
8.39 (s, 1H, ArH), 7.85–7.83 (d, 1H, ArH), 7.69 (d, 1H,
ArH), 7.32–7.28 (t, 1H, ArH), 7.05 (s, 1H, ArH), 6.84 (s, 1H,
ArH), 3.92 (s, 6 H, 2OCH3), 3.10–3.07 (t, 2 H, indane CH2),
2.66–2.62 (t, 2 H, indane CH2) ppm; 13C NMR (40 MHz,
DMSO-d6) d ppm= 165.8, 160.4, 154.8, 152.0, 148.5, 142.4,
135.9, 133.0, 130.8, 128.9, 123.5, 117.2, 110.1, 106.8, 92.2,
69.0, 56.5, 56.4, 29.5, 28.1 ppm; LCMS: m/z 504.99 M+),
Anal. Cald for C24H18BrN5O3: C,57.16;H,3.60;Br,15.84;
N,13.89;O,9.52; Found: C,57.89;H,3.90;N,13.76.
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4d2.5.6. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(3-methoxyphenyl)-2-oxo-1,2-
dihydropyridine-3,5-dicarbonitrile (4e)
Grey powder, Yield: 750 mg (90%), mp 245–248 C, 1H NMR
(400 MHz, DMSO-d6) d ppm= 10.09 (s, 2 H, NH2), 7.71 (d,
1H, ArH), 7.59 (t, 1H, ArH), 7.55 (s, 1H, ArH), 7.04 (s, 1H,
ArH), 6.94–6.91 (d, 1H, ArH), 6.83 (s, 1H, ArH), 3.92 (s, 6 H,
2OCH3), 3.78 (s, 3 H, OCH3), 3.10–3.07 (t, 2 H, indane CH2),
2.65 (t, 2 H, indane CH2) ppm;
13C NMR (40 MHz, DMSO-
d6) d ppm= 160.4, 158.1, 155.0, 151.2, 150.3, 148.5, 142.4,
134.6, 128.9, 127.6, 119.4, 117.9, 116.3, 110.1, 106.8, 92.0,
72.5, 56.5, 56.4, 54.9, 29.5, 28.1 ppm; LCMS: m/z 456.20
(M+), Anal. Cald for C25H21N5O4:C,65.93;H,4.65;N,
15.38;O,14.05; Found: C,65.98;H,4.71;N,15.45.
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O
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4e2.5.7. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(4-hydroxy-3-methoxyphenyl)-2-oxo-1,2-
dihydropyridine-3,5-dicarbonitrile (4f)
Off White powder, Yield: 515 mg (60%), mp 205–215 C, 1H
NMR (400 MHz, DMSO-d6) d ppm= 10.09 (s, 2 H, NH2),
7.79–7.76 (d, 1H, ArH), 7.49 (s, 1H, ArH), 7.13 (d, 1H,
ArH), 7.05 (s, 1H, ArH), 6.84 (s, 1H, ArH), 6.46 (s, 1H,
OH), 3.92 (s, 6 H, 2OCH3), 3.10–3.07 (t, 2 H, indane CH2),thoxy-1-indanone coupled with substituted pyridine as potential antimicrobial
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4 V.M. Patel et al.2.66–2.62 (t, 2 H, indane CH2) ppm;
13C NMR (40 MHz,
DMSO-d6) d ppm= 160.4, 155.0, 154.4, 148.5, 146.7, 142.4,
128.9, 126.7, 121.1, 117.2, 113.6, 111.5, 110.1, 91.1, 72.9,
56.5, 56.4, 56.3, 29.5, 28.1 ppm; LCMS: m/z 472.20 (M+),
Anal. Cald for C25H21N5O5: C,63.69;H,4.49;N,14.85;O,16.97;
Found: C,64.01;H,4.59;N,14.95.
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4f2.5.8. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(3-ﬂuorophenyl)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4g)
Offwhitepowder,Yield:280 mg(35%),mp220–225 C,1HNMR
(400 MHz,DMSO-d6)dppm= 10.07 (s,2H,NH2)7.90–7.87 (d,
1H, ArH), 7.81–7.78 (s, 1H, ArH), 7.65–7.59 (t, 1H, ArH), 7.23–
7.18 (d, 1H,ArH), 7.05 (s, 1H,ArH), 6.83 (s, 1H,ArH), 3.92 (s, 6
H,2OCH3),3.10–3.07(t,2H,indaneCH2),2.66–2.62(t,2H,indane
CH2)ppm;
13CNMR(40 MHz,DMSO-d6)dppm= 264.4,160.4,
155.6, 155.5, 151.5, 148.5, 142.4, 135.3, 129.0, 128.9, 121.2, 120.9,
116.1, 110.1, 106.8, 92.1, 72.2, 56.5, 56.4, 29.5, 28.1 ppm;LCMS:
m/z 444.0 (M+), Anal. Cald for C24H18FN5O3: C,65.01;
H,4.09;F,4.28;N,15.79;O,10.82; Found: C,65.08;
H,4.15;N,15.90.
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4g2.5.9. 6-Amino-4-(3-chlorophenyl)-1-(5,6-dimethoxy-2,3-
dihydro-1H-inden-1-ylideneamino)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4h)
Grey powder, Yield: 480 mg (57%), mp 228–230 C, 1H NMR
(400 MHz, DMSO-d6) d ppm= 10.3 (s, 2 H, NH2), 8.28 (s,
1H, ArH), 8.09–8.06 (d, 1H, ArH), 7.38–7.35 (d, 1H, ArH),
7.32–7.29 (t, 1H, ArH), 7.04 (s, 1H, ArH), 6.84 (s, 1H, ArH),
3.92 (s, 6 H, 2OCH3), 3.10–3.07 (t, 2 H, indane CH2), 2.66–
2.62 (t, 2 H, indane CH2) ppm;
13C NMR (40 MHz, DMSO-
d6) d ppm= 164.7, 160.4, 154.9, 150.7, 150.3, 148.5, 142.4,
134.0, 130.3, 129.9, 129.1, 128.9, 116.8, 113.4, 110.1, 106.8,
91.4, 69.7, 56.5, 56.4, 29.5, 28.1 ppm; LCMS: m/z 460.80
(M+), Anal. Cald for C24H18ClN5O3: C,62.68;H,3.95;Cl,7.71;
N,15.23;O,10.44; Found: C,62.89;H,3.85;N,15.29.Please cite this article in press as: Patel, V.M. et al., Novel derivatives of 5,6-dime
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4h2.5.10. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(2-methoxyphenyl)-2-oxo-1,2-
dihydropyridine-3,5-dicarbonitrile (4i)
Grey powder, Yield: 360 mg (43%), mp 216–220 C, 1H NMR
(400 MHz, DMSO-d6) d ppm= 10.5 (s, 2 H, NH2), 7.90–7.87
(d, 1H, ArH), 7.38–7.34 (t, 1H, ArH), 7.27–7.22 (t, 1H, ArH),
7.05 (s, 1H, ArH), 6.93–6.91 (d, 1H, ArH), 6.83 (s, 1H, ArH),
3.92 (s, 6 H, 2OCH3), 3.85 (s, 3 H, 2OCH3), 3.10–3.07 (t, 2 H,
indane CH2), 2.66–2.62 (t, 2 H, indane CH2) ppm;
13C NMR
(40 MHz, DMSO-d6) d ppm= 163.7, 160.4, 157.4, 150.9,
150.3, 148.5, 142.4, 132.6, 129.6, 128.9, 128.2, 119.4, 117.2,
110.1, 106.8, 81.7, 70.8, 56.5, 56.4, 55.6, 29.5, 28.1 ppm; LCMS:
m/z 456.80 (M+), Anal. Cald for C25H21N5O4:
C,65.93;H,4.65;N,15.38;O,14.05; Found: C,66.05;H,4.70;
N,15.44.
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4i2.5.11. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(3-nitrophenyl)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4j)
Grey powder, Yield: 480 mg (56%), mp 224–228 C, 1H NMR
(400 MHz, DMSO-d6) d ppm= 10.7 (s, 2 H, NH2), 8.94 (s,
1H, ArH), 8.38–8.36 (d, 1H, ArH), 8.24 (d, 1H, ArH), 7.64–
7.60 (t, 1H, ArH), 7.04 (s, 1H, ArH), 6.84 (s, 1H, ArH), 3.92
(s, 6 H, 2OCH3), 3.07 (t, 2 H, indane CH2), 2.66–2.62 (t, 2
H, indane CH2) ppm;
13C NMR (40 MHz, DMSO-d6) d
ppm= 167.2, 160.4, 154.8, 151.7, 148.5, 146.0, 142.4, 134.7,
131.0, 130.7, 127.1, 125.3, 118.1, 114.6, 110.1, 106.8, 91.29,
71.52, 56.5, 56.4, 29.5, 28.1 ppm; LCMS: m/z 469.00 (M+),
Anal. Cald for C24H18N6O5:C,61.27;H,3.86;N,17.86;O,17.00;
Found: C,61.58;H,3.95;N,17.98.
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Derivatives of 5,6-dimethoxy-1-indanone2.5.12. 6-Amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-4-(2-ethoxyphenyl)-2-oxo-1,2-dihydropyridine-
3,5-dicarbonitrile (4k)
Off White powder, Yield: 430 mg (50%), mp 226-229 C, 1H
NMR (400 MHz, DMSO-d6) d ppm= 10.7 (s, 2 H, NH2),
7.96–7.94 (d, 1H, ArH), 7.38–7.34 (t, 1H, ArH), 7.26–7.22 (t,
1H, ArH), 7.05 (s, 1H, ArH), 6.84 (s, 1H, ArH), 6.77 (d, 1H,
ArH), 4.18–4.13 (m, 2 H, CH2), 3.92 (s, 6 H, 2OCH3), 3.10–
3.07 (t, 2 H, indane CH2), 2.65–2.62 (t, 2 H, indane CH2),
1.40–1.37 (t, 3 H, CH3) ppm; 13C NMR (40 MHz, DMSO-d6)
d ppm= 164.7, 160.4, 154.9, 150.7, 150.3, 148.5,142.4, 135.3,
129.0, 128.9, 121.2, 120.9,118.1, 114.6, 110.1, 106.8, 91.29,
71.52, 56.5, 56.4, 29.5, 28.1 ppm; LCMS: m/z 469.00 (M+),
Anal. Cald for C26H23N5O4: C,66.51;H,4.94;N,14.92;O,13.63;
Found: C,66.81;H,4.85;N;14.80.
N N
O
H2N
O
O
N
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O
4k2.6. Antimicrobial activity
The in vitro antimicrobial activity of the compounds 4(a–k)
was studied by disc agar diffusion technique at different con-
centrations of 50 mg/ml using Dimethylformamide as solvent.
The speciﬁc bacterial culture was spread uniformly over nutri-
ent agar in Petri plates. Then the test solution, standard and
control of known similar concentrations were spotted in sam-
ple wells at speciﬁc distances. The zones of inhibition were
measured after 24 h. The in vitro antibacterial activity was per-
formed against Gram-positive bacteria including Staphylococ-
cus aureus (MTCC 96), Streptococcus pyogenes (MTCC 442)Table 1 Antibacterial and Antifungal activity of novel compounds
Compound no. Zone diameter of growth inhibition in mm
Antibacterial activity
Gram +ve Gram
S. aureus S. pyogenes E. co
4a 14 14 16
4b 11 15 15
4c 19 18 17
4d 20 15 14
4e 10 14 14
4f 13 15 15
4g 12 17 16
4h 15 14 14
4i 21 14 17
4j 11 16 17
4k 12 15 22
Ampicilline 18 19 20
Chloramphenicol 21 20 23
Fluconazole – – –
Bold ﬁgures indicates better or equivalent activity compared to existing d
Please cite this article in press as: Patel, V.M. et al., Novel derivatives of 5,6-dime
agents. Arabian Journal of Chemistry (2014), http://dx.doi.org/10.1016/j.arabjc.2014and Gram negative bacteria including Escherichia coli (MTCC
443), Pseudomonas aeruginosa (MTCC 424). Yeast including
Candida albicans (MTCC 227) and fungi Aspergillus clavatus
(MTCC 1323) were used to test antifungal activity. Known
antibiotics like Ampicilline and Chloramphenicol (the reference
anti bacterial drugs) and Fluconazole (the reference antifungal
drug) were used for comparison. The antimicrobial activities
are summarized in Table 1.
3. Result and discussion
A series of 6-amino-1-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-
ylideneamino)-2-oxo-4-aryl-1,2-dihydropyridine-3,5-dicarbo-
nitrile derivatives 4(a–k) was prepared from the reaction of 2-
Cyano-N0-(5,6-dimethoxy-2,3-dihydro-1H-inden-1-ylidene)
aceto-hydrazide with 2-arylidenemalononitrile in the presence
of a catalytic amount piperidine to provide the title com-
pounds. The purity of compounds was analysed by TLC.
The structures of all compounds were conﬁrmed by 1H-
NMR, 13C-NMR, Mass analysis and Elemental analyses.
The supporting information can be seen from the spectral data
which conﬁrm the formation of claimed compounds.
The antibacterial activity of newly synthesized compounds
4(a–k) was performed by the agar disc-diffusion method
against Gram-positive bacteria S. aureus, S. pyogenes and
Gram negative bacteria including E. coli, P. aeruginosa. Yeast
including Candida albicans and fungi Aspergillus clavatus were
used. Results are summarized in Table 1. Zone of inhibition
was compared with the reference standard Ampicilline, Chlor-
amphenicol (antibacterial agent) and Fluconazole (antifungal
agent). From the result of antibacterial data, compounds 4c,
4d, 4i, 4k shows good activity as antibacterial agent while com-
pounds 4c, 4h, 4i, 4j shows good activity as antifungal agent.
4. Conclusion
A series of novel 6-amino-1-(5,6-dimethoxy-2,3-dihydro-1H-
inden-1-ylideneamino)-2-oxo-4-aryl-1,2-dihydropyridine-3,5-at concentration 50 mg/ml in DMF (4a–k).
Antifungal activity
ve C. albicans A. clavatus
li P. aeruginosa
14 18 20
14 20 21
14 20 23
11 20 18
14 21 16
12 17 13
13 19 18
11 20 23
14 23 19
13 21 18
13 20 23
20 – –
21 – –
– 24 24
rugs.
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6 V.M. Patel et al.dicarbonitrile derivatives were designed and synthesized, and
their structures were characterized by 1H NMR, mass spec-
troscopy and elemental analysis. The bacterial and fungicidal
activities of the new compounds were evaluated. The results
of preliminary bioassays indicate that a number of these mol-
ecules exhibit antibacterial activities against Gram-positive
and Gram-negative bacteria as well as antifungal stains, which
are comparable to commercially available drugs. The modiﬁ-
cation of the Pyridine ring of the parent compound offers a
promising prospect and more active analogues are expected
to be found.Appendix A. Supplementary data
Supplementary data associated with this article can be found,
in the online version, at http://dx.doi.org/10.1016/
j.arabjc.2014.07.014.
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